Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Neurotrauma Reports|December 8, 2025
Blood Levels of Dendritic Cell Populations in Patients with Moderate to Severe Traumatic Brain InjuryPatrik Fridh, Ebba Katsler, Niklas Marklund, et al.
Brain Communications|June 5, 2023
Antibodies from serum and CSF of multiple sclerosis patients bind to oligodendroglial and neuronal cell-linesFaisal Hayat Nazir, Anna Wiberg, Malin Müller, et al.
Frontiers in Immunology|March 8, 2021
Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and TreatmentsStefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, et al.
JAMA Network Open|May 11, 2022
Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With RituximabAndreas Tolf, Anna Wiberg, Malin Müller, et al.
Toxicology Reports|July 8, 2020
Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic interventionAikaterini Nasi, Stephanie McArdle, Gustav Gaudernack, et al.
Molecular Cancer Therapeutics|March 13, 2015
The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responsesLisa Christiansson, Stina Söderlund, Sara Mangsbo, et al.
British Journal of Cancer|April 1, 2016
Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patientsAngelica Loskog, Aglaia Maleka, Sara Mangsbo, et al.
New Biotechnology|July 17, 2021
Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cellsAntonino Napoleone, Ida Laurén, Triinu Linkgreim, et al.
Clinical & Translational Immunology|April 21, 2022
Impact of SARS-CoV-2 infection on vaccine-induced immune responses over timeSebastian Havervall, Ulrika Marking, Nina Greilert-Norin, et al.
Immunology|April 6, 2011
Both CD4+ FoxP3+ and CD4+ FoxP3- T cells from patients with B-cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitroCamilla A Lindqvist, Lisa H Christiansson, Ingrid Thörn, et al.
Pageof 3